Meeting of the Advisory Council on Blood Stem Cell Transplantation, 55466 [2020-19690]

Download as PDF 55466 Federal Register / Vol. 85, No. 174 / Tuesday, September 8, 2020 / Notices information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of respondents Form name Total responses Average burden per response (in hours) Total burden hours STAR LRP Application ......................................................... Authorization for Disclosure of Loan Information Form ....... Privacy Act Release Authorization Form ............................. Employment Verification Form ............................................. Site Application .................................................................... 300 300 300 300 400 1 1 1 1 1 300 300 300 300 400 .50 .50 .50 .50 1.00 150 150 150 150 400 Total .............................................................................. 1,600 ........................ 1,600 ........................ 1000 HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2020–19776 Filed 9–4–20; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the Advisory Council on Blood Stem Cell Transplantation Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces that the Secretary’s Advisory Council on Blood Stem Cell Transplantation (ACBSCT) has scheduled a public meeting. Information about ACBSCT and the agenda for this meeting can be found on the ACBSCT website at https:// bloodstemcell.hrsa.gov/about/advisorycouncil. DATES: September 25, 2020, from 12:00 p.m.–6:00 p.m. Eastern Time (ET). ADDRESSES: This meeting will be held by webinar and conference call. The webinar link, conference call-in number, registration information, and SUMMARY: jbell on DSKJLSW7X2PROD with NOTICES Number of responses per respondent VerDate Sep<11>2014 16:32 Sep 04, 2020 Jkt 250001 meeting materials can be accessed through the registration link on the ACBSCT website at https:// bloodstemcell.hrsa.gov/about/advisorycouncil. FOR FURTHER INFORMATION CONTACT: Robert Walsh, Designated Federal Official, (DFO), at Division of Transplantation, HRSA, 5600 Fishers Lane, Rockville, Maryland 20857; 301– 443–6839; or ACBSCTHRSA@hrsa.gov. SUPPLEMENTARY INFORMATION: ACBSCT provides advice and recommendations to the Secretary of HHS (Secretary) and the HRSA Administrator on the activities of the C.W. Bill Young Cell Transplantation Program (CWBYCTP) and the National Cord Blood Inventory (NCBI) Program. The principal purpose of these programs is to make blood stem cells from adult donors and cord blood units available for patients who need a transplant to treat life-threatening conditions such as leukemia, and who lack a suitably matched relative who can be the donor. During the September 25, 2020, meeting, the ACBSCT will receive updates on the operation of the CWBYCTP and the NCBI and discuss cord blood as a continued source of blood stem cells for transplant in the context of other available sources of blood stem cells for transplant. Agenda items are subject to change as priorities dictate. Refer to the ACBSCT website for any updated information concerning the meeting. Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to ACBSCT should be sent to Robert Walsh, DFO, PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 using the contact information above at least three business days prior to the meeting. Individuals who plan to attend and need special assistance or another reasonable accommodation should notify Robert Walsh at the address and phone number listed above at least 10 business days prior to the meeting. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2020–19690 Filed 9–4–20; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the President’s Council on Sports, Fitness, and Nutrition Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services (HHS) is hereby giving notice that the President’s Council on Sports, Fitness & Nutrition (PCSFN) will hold its annual meeting. The meeting will be open to the public. DATES: The meeting will take place on Thursday, September 17, 2020, from 1:00 p.m. to 5:00 p.m. (EDT). ADDRESSES: The meeting will be held virtually using an online platform. To register to attend the meeting, please visit the registration website at https:// kauffmaninc.adobeconnect.com/ch_ pcsfn_sept2020/event/event_info.html. FOR FURTHER INFORMATION CONTACT: Jennifer Anne Bishop, Sc.D., M.P.H., Designated Federal Officer for the PCSFN, 1101 Wootton Parkway, Suite SUMMARY: E:\FR\FM\08SEN1.SGM 08SEN1

Agencies

[Federal Register Volume 85, Number 174 (Tuesday, September 8, 2020)]
[Notices]
[Page 55466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19690]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Council on Blood Stem Cell 
Transplantation

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Secretary's Advisory Council on Blood Stem 
Cell Transplantation (ACBSCT) has scheduled a public meeting. 
Information about ACBSCT and the agenda for this meeting can be found 
on the ACBSCT website at https://bloodstemcell.hrsa.gov/about/advisory-council.

DATES: September 25, 2020, from 12:00 p.m.-6:00 p.m. Eastern Time (ET).

ADDRESSES: This meeting will be held by webinar and conference call. 
The webinar link, conference call-in number, registration information, 
and meeting materials can be accessed through the registration link on 
the ACBSCT website at https://bloodstemcell.hrsa.gov/about/advisory-council.

FOR FURTHER INFORMATION CONTACT: Robert Walsh, Designated Federal 
Official, (DFO), at Division of Transplantation, HRSA, 5600 Fishers 
Lane, Rockville, Maryland 20857; 301-443-6839; or [email protected].

SUPPLEMENTARY INFORMATION: ACBSCT provides advice and recommendations 
to the Secretary of HHS (Secretary) and the HRSA Administrator on the 
activities of the C.W. Bill Young Cell Transplantation Program 
(CWBYCTP) and the National Cord Blood Inventory (NCBI) Program. The 
principal purpose of these programs is to make blood stem cells from 
adult donors and cord blood units available for patients who need a 
transplant to treat life-threatening conditions such as leukemia, and 
who lack a suitably matched relative who can be the donor.
    During the September 25, 2020, meeting, the ACBSCT will receive 
updates on the operation of the CWBYCTP and the NCBI and discuss cord 
blood as a continued source of blood stem cells for transplant in the 
context of other available sources of blood stem cells for transplant. 
Agenda items are subject to change as priorities dictate. Refer to the 
ACBSCT website for any updated information concerning the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting. Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to ACBSCT should be 
sent to Robert Walsh, DFO, using the contact information above at least 
three business days prior to the meeting.
    Individuals who plan to attend and need special assistance or 
another reasonable accommodation should notify Robert Walsh at the 
address and phone number listed above at least 10 business days prior 
to the meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-19690 Filed 9-4-20; 8:45 am]
BILLING CODE 4165-15-P